Cargando…
Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
Autor principal: | Frontiers Production Office |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107049/ https://www.ncbi.nlm.nih.gov/pubmed/37077813 http://dx.doi.org/10.3389/fphar.2023.1188062 |
Ejemplares similares
-
Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
por: Frontiers Production Office,
Publicado: (2022) -
Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
por: Frontiers Production Office,
Publicado: (2023) -
Erratum: Exploring the pharmacological action mechanism of Ligusticum Chuanxiong-Piper Longum couplet medicines on the treatment of migraine based on network pharmacology
por: Frontiers Production Office,
Publicado: (2022) -
Erratum: Mechanism Underlying Acupuncture Therapy in Spinal Cord Injury: A Narrative Overview of Preclinical Studies
por: Frontiers Production Office,
Publicado: (2022) -
Erratum: The Botanical Drug PBI-05204, a Supercritical CO(2) Extract of Nerium Oleander, is Synergistic With Radiotherapy in Models of Human Glioblastoma
por: Frontiers Production Office,
Publicado: (2022)